<p>Tigermed (03347.HK) announced its full-year results for the year ended December last year, with revenue of RMB 6.833 billion, an increase of 3.5% year-on-year. Net profit was RMB 888 million, an increase of 119.2% year-on-year; earnings per share were RMB 1.04. A final dividend of RMB 0.126 was declared</p>

300347

516820

159849

03347

513290

516500

516930

159837

<p>Tigermed announced its full-year results for the year ending December last year, with a revenue of RMB 6.833 billion, an increase of 3.5% year-on-year. The net profit was RMB 888 million, an increase of 119.2% year-on-year; earnings per share were RMB 1.04. A final dividend of RMB 0.126 was declared</p>

AASTOCKS

Tigermed

Ping An CSI Medicine and Medical Device Innovation ETF

China Merchants CSI Biotechnology Theme ETF

First Trust NYSE Arca Biotech Index Fd

TIGERMED

China Universal NASDAQ Biotechnology Technology ETF(QDII)

ChinaAMC CSI Biotechnology Theme ETF

Minsheng Royal CSI Biotechnology Theme ETF

E Fund CSI Biotechnology Theme ETF

"Performance" Tigermed's annual net profit rises 119.2% to RMB 888 million, with a final dividend of RMB 0.126